Evaluation of the Potential of Raman Microspectroscopy for Prediction of Chemotherapeutic Response to Cisplatin in Lung Adenocarcinoma
Available under a Creative Commons Attribution Non-Commercial Share Alike 4.0 International Licence
The study of the interaction of anticancer drugs with mammalian cells in vitro is important to elucidate the mechanisms of action of the drug on its biological targets. In this context, Raman spectroscopy is a potential candidate for high throughput, noninvasive analysis. To explore this potential, the interaction of cis-Diamminedichloroplatinum (II) (Cisplatin) with a human lung adenocarcinoma cell line (A549) was investigated using Raman microspectroscopy. The results were correlated with parallel measurements from the MTT cytotoxicity assay, which yielded an IC50 value of 1.2±0.2 μM. To further confirm the spectral results, Raman spectra were also acquired from DNA extracted from A549 cells exposed to cisplatin and from unexposed controls. Partial least squares (PLS) multivariate regression and PLS Jack-knifing were employed to highlight spectral regions which varied in a statistically significant manner with exposure to cisplatin and with the resultant changes in cellular physiology measured by the MTT assay. The results demonstrate the potential of the cellular Raman spectrum to non-invasively elucidate spectral changes that have their origin either in the biochemical interaction of external agents with the cell or its physiological response, allowing the prediction of the cellular response and the identification of the origin of the chemotherapeutic response at a molecular level in the cell.
Nawaz, H. et al (2010) Evaluation of the potential of Raman microspectroscopy for prediction of chemotherapeutic response to cisplatin in lung adenocarcinoma. Analyst,vol. 135, no.12 pp.3070-6. doi:10.1039/c0an00541j
Technology Sector Research (Strand III) programme of the Irish Higher Education Authority and the Irish HEA Programme for Research in Third Level Institutions, Cycle 4 National Biophotonics and Imaging Platform for Ireland (NBIPI).
Analyst, Vol.135, 2010, pp.3169-3177 DOI: 10.1039/C0AN00541J